HR 1715, the Public Health Funding Restoration Act, restores annual funding for the Prevention and Public Health Fund to $2 billion starting in fiscal year 2026. This bill directly affects federal public health programs, including the CDC’s immunization initiatives and state/local health departments, by reversing prior funding cuts. It amends the Affordable Care Act to set the annual funding level at $2 billion, enabling continued support for evidence-based prevention programs like childhood lead poisoning prevention, tobacco cessation, and immunizations. The restored funding aims to maintain existing programs proven to reduce healthcare costs and improve community health outcomes. This change specifically targets the Prevention and Public Health Fund (Section 4002 of the ACA) without creating new programs.
The Rural Health Focus Act (S 403) creates a new Office of Rural Health within the CDC, headed by a director appointed by the CDC Director. This office will directly serve rural communities by coordinating CDC research on rural health challenges, developing policies to improve care (including telehealth), and awarding grants to support rural health initiatives. Key mechanisms include acting as the CDC’s main contact for rural health issues, identifying healthcare disparities in rural areas, and collaborating with other federal health offices to avoid duplication. The bill aims to address specific health access and outcomes gaps faced by people living in rural populations through targeted federal coordination and support.
The LINC VA Act (S 3303) establishes a pilot program to create or enhance a community integration platform at VA medical facilities, helping veterans access coordinated support services like housing, healthcare, job training, and mental health care through partnerships with community organizations. The platform must connect existing local services, use standardized health screening tools (based on ICD-10 codes for social determinants), and track referral outcomes to improve service coordination. It requires the VA to implement this at five or more diverse VA facilities - including rural and under-resourced sites - within one year of enactment. The program collects veteran data on social needs to better align VA care with community resources, with a report due to Congress within three years.
HR 211, the Equal Access to Contraception for Veterans Act, eliminates out-of-pocket costs for specific contraceptives for veterans using VA healthcare. It amends Section 1722A of Title 38 to prohibit the VA from charging veterans copayments for contraceptive items that must be covered without cost-sharing under federal law (as required by Section 2713(a)(4) of the Public Health Service Act). This means veterans will not pay any amount for contraceptives covered by the federal mandate, such as birth control pills or IUDs, when obtained through the VA system. The bill directly affects veterans enrolled in VA healthcare seeking contraceptive services, ensuring no additional costs beyond what is already mandated for these items.
S 483, the Responsibility in Drug Advertising Act of 2025, prohibits direct-to-consumer advertising of newly approved drugs for the first three years after approval, with a possible waiver for the third year if the drug sponsor demonstrates public health benefits. After the initial three years, the FDA may ban such advertising if post-approval safety data shows significant health risks. The bill requires the FDA to update its advertising regulations within one year of enactment to implement these rules. It applies only to drugs approved under specific FDA pathways after a one-year cutoff before the law's effective date.
HR 1669 reauthorizes the SOAR to Health and Wellness Training Program, which trains healthcare professionals to address patient health behaviors through a "Stop, Observe, Ask, and Respond" approach. The bill extends the program's funding period from fiscal years 2020-2024 to 2026-2030 under the Public Health Service Act. This change ensures continued federal support for the training program without altering its existing structure or eligibility. The program directly affects healthcare providers participating in the training and health centers offering it.
HR 7391, the Community Health Center Drug Pricing Protection Act, requires that Federally Qualified Health Centers (FQHCs) pay the discounted 340B ceiling price for covered drugs **at the time of purchase**, not later through rebates or adjustments. This directly affects FQHCs, which rely on 340B discounts to provide affordable care to low-income patients. The bill amends the Public Health Service Act to prohibit manufacturers from entering agreements where FQHCs initially pay more than the ceiling price, with later reimbursement. It takes effect immediately upon enactment for all new drug purchases and applies to existing agreements starting then.
Further Additional Continuing Appropriations and Other Extensions Act, 2025 This bill provides continuing FY2025 appropriations for federal agencies through April 11, 2025. It also extends various expiring programs and authorities, including several public health programs. Specifically, the bill provides continuing FY2025 appropriations to federal agencies through the earlier of April 11, 2025, or the enactment of the applicable appropriations act. It is known as a continuing resolution (CR) and prevents a government shutdown that would otherwise occur if the FY2025 appropriations bills have not been enacted when the existing CR expires on March 14, 2025. The CR funds most programs and activities at the FY2024 levels with some exceptions that provide funding flexibility and additional appropriations for various programs. For example, the CR provides additional emergency funding for the Federal Emergency Management Agency's Disaster Relief Fund, permits the Navy to apportion funds at the rate necessary to fund the Columbia-class submarine program and cost increases for certain shipbuilding programs, and provides additional funding for the Office of Navajo and Hopi Relocation. In addition, the bill extends several expiring programs and authorities, including several public health, Medicare, and Medicaid authorities and programs; authorities related to the Commodity Futures Trading Commission whistleblower program; authorities for the Department of Homeland Security and the Department of Justice to take actions to mitigate a credible threat from an unmanned aircraft system; the special assessment on nonindigent persons or entities convicted of certain offenses involving sexual abuse or human trafficking; and the National Cybersecurity Protection System.
S 2699, the Geriatrics Workforce Improvement Act, authorizes $48,245,000 annually for fiscal years 2026 through 2030 to fund geriatrics education and training programs under the Public Health Service Act. This funding directly supports healthcare providers and training institutions focused on elder care by expanding resources for developing geriatric specialists. The bill’s key provision replaces a prior funding reference with this specific, multi-year appropriation to strengthen the geriatric healthcare workforce. It does not change eligibility or create new requirements, only establishing dedicated federal funding for existing geriatrics training initiatives.
The GIFT Act of 2025 prohibits hospitals, critical access hospitals, and rural emergency hospitals from considering a patient's vaccination status when determining organ transplant recipients. This law directly affects organ transplant candidates and healthcare facilities by requiring that recipient selection be based solely on medical criteria, not vaccination history. The bill amends the Social Security Act to add a new provision explicitly banning the use of vaccination status in transplant decisions. This policy change ensures that access to life-saving organ transplants is not influenced by vaccination records.
